Cargando…

Subcutaneous Immunoglobulin for Antibody Deficiency in Antineutrophil Cytoplasmic Antibody (ANCA)-associated Vasculitis

Objectives Intravenous immunoglobulin G (IVIG) is used to treat antineutrophil cytoplasmic antibody (ANCA) patients with recurrent infections as a result of hypogammaglobulinemia (HG) induced by treatment regimens. We sought to characterize clinical features, treatment, and outcomes for patients tre...

Descripción completa

Detalles Bibliográficos
Autores principales:	Kant, Sam, Azar, Antoine, Gapud, Eric J, Antiochos, Brendan, Manno, Rebecca, Seo, Philip, Geetha, Duvuru
Formato:	Online Artículo Texto
Lenguaje:	English
Publicado:	Cureus 2019
Materias:	Allergy/Immunology
Acceso en línea:	https://www.ncbi.nlm.nih.gov/pmc/articles/PMC6957027/ https://www.ncbi.nlm.nih.gov/pubmed/31938649 http://dx.doi.org/10.7759/cureus.6367

Ejemplares similares

Characteristics and Outcomes of COVID-19 in Patients With Antineutrophil Cytoplasmic Antibody–Associated Vasculitis
por: Kant, Sam, et al.
Publicado: (2020)

Long-term Clinical Course of Antineutrophil Cytoplasmic Antibody-associated Vasculitis Patients off Maintenance Therapy
por: Gapud, Eric J, et al.
Publicado: (2018)

A RARE CASE OF ANTINEUTROPHIL CYTOPLASMIC ANTIBODIES (ANCA)-ASSOCIATED VASCULITIS IN THE SETTING OF COVID-19 INFECTION
por: RATH, PALAK, et al.
Publicado: (2022)

Antibody response to COVID-19 booster vaccine in rituximab-treated patients with anti–neutrophil cytoplasmic antibody–associated vasculitis
por: Kant, Sam, et al.
Publicado: (2022)

Bamlanivimab Decreases Severe Outcomes of SARS-CoV-2 Infection in Patients With Antineutrophil Cytoplasmic Antibody Vasculitis
por: Ghosh, Jyotsna, et al.
Publicado: (2021)

Tixagevimab and Cilgavimab (Evusheld) in Rituximab-treated Antineutrophil Cytoplasmic Antibody Vasculitis Patients
por: Aqeel, Faten, et al.
Publicado: (2022)

SARS-CoV-2 Vaccine Response in Patients With Antineutrophil Cytoplasmic Autoantibody–Associated Vasculitis
por: Floyd, Lauren, et al.
Publicado: (2021)

The impact of COVID-19 pandemic on patients with ANCA associated vasculitis
por: Kant, Sam, et al.
Publicado: (2020)

Comparisons of Guidelines and Recommendations on Managing Antineutrophil Cytoplasmic Antibody–Associated Vasculitis
por: Geetha, Duvuru, et al.
Publicado: (2018)

Antineutrophil cytoplasmic antibodies (ANCA) – their role in pathogenesis, diagnosis, and treatment monitoring of ANCA-associated vasculitis
por: FIJOŁEK, JUSTYNA, et al.
Publicado: (2020)

Tofacitinib-Induced Antineutrophil Cytoplasmic Antibodies (ANCA)-Associated Vasculitis With Crescentic Glomerulonephritis
por: Asemota, Uyioghosa, et al.
Publicado: (2021)

Suspicion Is Key: Diagnosing Elusive Cytoplasmic Antineutrophil Cytoplasmic Antibody (c-ANCA)-Positive Vasculitis
por: Crowe, Timothy P, et al.
Publicado: (2022)

Impact of rituximab on humoral response to COVID-19 booster vaccine and antibody kinetics in patients with anti–neutrophil cytoplasmic antibody vasculitis
por: Kant, Sam, et al.
Publicado: (2021)

Patient Outcomes in Renal-Limited Antineutrophil Cytoplasmic Antibody Vasculitis With Inactive Histology
por: Novick, Tessa K., et al.
Publicado: (2018)

Cytoplasmic Antineutrophil Cytoplasmic Antibodies (C-ANCA) Vasculitis: An Uncommon Complication After Stem Cell Transplantation
por: Raja, Ahmad, et al.
Publicado: (2022)

A Case of Antineutrophil Cytoplasmic Antibodies (ANCA)-Associated Vasculitis Post COVID-19 Vaccination
por: Al-Yafeai, Zaki, et al.
Publicado: (2022)

A Rare Case of Nephrotic-Range Proteinuria in Antineutrophil Cytoplasmic Antibodies (ANCA)-Associated Vasculitis
por: Nasr, Rabih, et al.
Publicado: (2022)

Systematic Review and Metaanalysis of Worldwide Incidence and Prevalence of Antineutrophil Cytoplasmic Antibody (ANCA) Associated Vasculitis
por: Redondo-Rodriguez, Rocío, et al.
Publicado: (2022)

Myeloperoxidase-antineutrophil cytoplasmic antibody (ANCA)-associated systemic vasculitis developed from ANCA negative renal limited vasculitis: A case report
por: Li, Xiao-li, et al.
Publicado: (2017)

Immunoglobulin levels and infection risk with rituximab induction for anti-neutrophil cytoplasmic antibody-associated vasculitis
por: Shah, Shivani, et al.
Publicado: (2017)

Clinical Utility of Serial Measurements of Antineutrophil Cytoplasmic Antibodies Targeting Proteinase 3 in ANCA-Associated Vasculitis
por: Thompson, Gwen E., et al.
Publicado: (2020)

Hydralazine-Induced Antineutrophil Cytoplasmic Antibody (ANCA)-Associated Vasculitis: A Case Report and Literature Review
por: Alawneh, Diala, et al.
Publicado: (2022)

Antineutrophil Cytoplasmic Antibody (ANCA)-Associated Vasculitis (AAV) Masquerading As Mononeuritis Multiplex: A Case Report
por: Patel, Anandkumar, et al.
Publicado: (2023)

Cutaneous Leukocytoclastic Vasculitis Induced by Apixaban and/or Rivaroxaban With Seronegative Anti-Neutrophil Cytoplasmic Antibody (ANCA) Titers: A Case Report and Literature Review
por: El-Sabbagh, Mohamad, et al.
Publicado: (2023)

Pulmonary Fibrosis in Antineutrophil Cytoplasmic Antibodies (ANCA)-Associated Vasculitis: A Series of 49 Patients and Review of the Literature
por: Comarmond, Cloé, et al.
Publicado: (2014)

Antineutrophil Cytoplasmic Antibody (ANCA)-Associated Renal Vasculitis After COVID-19 Infection: A Case Report
por: Kataria, Saurabh, et al.
Publicado: (2022)

Levamisole adulterated cocaine associated ANCA vasculitis: review of literature and update on pathogenesis
por: Jin, Qiuyu, et al.
Publicado: (2018)

Rituximab-associated hypogammaglobulinemia in ANCA-associated vasculitis: Incidence and time course
por: Tariq, Anam, et al.
Publicado: (2022)

Subarachnoid Hemorrhage in Autoimmune Vasculitis: A Rare Presentation of Systemic Lupus Erythematosus-Antineutrophil Cytoplasmic Autoantibody-Associated Vasculitis Overlap Syndrome
por: Palleti, Sujith K, et al.
Publicado: (2023)

Co-existing proteinase 3-antineutrophil cytoplasmic antibody-associated vasculitis with immunoglobulin A nephropathy
por: Kucuk, Adem, et al.
Publicado: (2016)

Older patients with ANCA-associated vasculitis and dialysis dependent renal failure: a retrospective study
por: Manno, Rebecca L., et al.
Publicado: (2015)

Pulmonary Fibrosis in Antineutrophil Cytoplasmic Antibodies (ANCA)-Associated Vasculitis: A Series of 49 Patients and Review of the Literature: Erratum
Publicado: (2015)

Antineutrophilic Cytoplasmic Antibody Positive Vasculitis Associated with Methimazole Use
por: Shikha, Deep, et al.
Publicado: (2015)

Stress and Disease Onset in Antineutrophil Cytoplasmic Antibody-Associated Vasculitis
por: Golemati, Christina V., et al.
Publicado: (2017)

The role of mycophenolate in the treatment of antineutrophil cytoplasmic antibody-associated vasculitis
por: Koukoulaki, Maria, et al.
Publicado: (2019)

Treatment of Aggressive Antineutrophil Cytoplasmic Antibody–Associated Vasculitis With Eculizumab
por: Huizenga, Noah, et al.
Publicado: (2019)

Antineutrophil Cytoplasmic Antibody-Associated Vasculitis Update: Genetic Pathogenesis
por: Li, Weiran, et al.
Publicado: (2021)

Isolated Antineutrophil Cytoplasmic Antibody-Associated Coronary Vasculitis and Valvulitis
por: Kim, Yoon Kook, et al.
Publicado: (2021)

Polypharmacy in US Medicare beneficiaries with antineutrophil cytoplasmic antibody vasculitis
por: Cao, Binxin, et al.
Publicado: (2023)

Antieosinophil Antibodies Alone or in Combination with Antineutrophil Cytoplasmic Antibodies (ANCA) Detected in Different Autoimmune Conditions
por: Dieckmann, Régis, et al.
Publicado: (2023)

Cannot write session to /tmp/vufind_sessions/sess_n0tr3bc6n0h0snfdpu4mmeda6n